UA103908C2 - Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy - Google Patents

Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy

Info

Publication number
UA103908C2
UA103908C2 UAA201105239A UAA201105239A UA103908C2 UA 103908 C2 UA103908 C2 UA 103908C2 UA A201105239 A UAA201105239 A UA A201105239A UA A201105239 A UAA201105239 A UA A201105239A UA 103908 C2 UA103908 C2 UA 103908C2
Authority
UA
Ukraine
Prior art keywords
talinolol
assessment
patients
coronary disease
left ventricular
Prior art date
Application number
UAA201105239A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михаил Васильевич Бычко
Николай Васильевич Ришко
Наталья Николаевна Демко
Ярослав Михайлович Бычка
Original Assignee
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет" filed Critical Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAA201105239A priority Critical patent/UA103908C2/en
Publication of UA103908C2 publication Critical patent/UA103908C2/en

Links

Landscapes

  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

The invention relates to a medicine, in particular to cardiology, and concerns a method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and. The method provides Doppler echocardiography of patient at rest before and after talinolol therapy and determination of transmitral blood flow by measurement of early diastolic filling rate. The efference of treatment is assessed according to the early diastolic filling rate change.
UAA201105239A 2011-04-26 2011-04-26 Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy UA103908C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201105239A UA103908C2 (en) 2011-04-26 2011-04-26 Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201105239A UA103908C2 (en) 2011-04-26 2011-04-26 Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy

Publications (1)

Publication Number Publication Date
UA103908C2 true UA103908C2 (en) 2013-12-10

Family

ID=52285355

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201105239A UA103908C2 (en) 2011-04-26 2011-04-26 Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy

Country Status (1)

Country Link
UA (1) UA103908C2 (en)

Similar Documents

Publication Publication Date Title
UA103908C2 (en) Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy
UA105641C2 (en) Method for the assessment of acebutolol therapy efficiency in patients with coronary disease with cardiac angina and arterial hypertension with left ventricular hypertrophy
UA105642C2 (en) Method for the assessment of labetalol therapy efficiency in patients with coronary disease with cardiac angina and arterial hypertension with left ventricular hypertrophy
UA104291C2 (en) Method for evaluation of effectiveness clenthiazem therapy of patients with coronary disease with stenocardia and diastolic dysfunction in left ventricular hypertrophy
UA104734C2 (en) Evaluation of effectiveness of therapy with pindolol in patients with coronary disease with angina and diastolic dysfunction in left ventricular hypertrophy
UA104423C2 (en) Method for evaluation of effectiveness of moexipril therapy in patients with coronary disease with stenocardia and diastolic dysfunction in left ventricular hypertrophy
UA104733C2 (en) Evaluation of effectiveness of therapy with carvedilol in patients with coronary disease with angina and diastolic dysfunction in left ventricular hypertrophy
UA104723C2 (en) Evaluation of effectiveness of therapy with quinapril in patients with coronary disease with angina and diastolic dysfunction in left ventricular hypertrophy
UA64628U (en) Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA64627U (en) Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA54819U (en) Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA64585U (en) method for estimation of efficiency of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type with metoprolol
UA95183C2 (en) Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61995U (en) method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
UA61054U (en) method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA68461U (en) Method for assessing efficacy of s-amlodipine in treating ischemic heart disease with angina and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA65055U (en) method for estimation of efficiency of treatment with ALPRENOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
UA61052U (en) method for evaluating the effectiveness of treatment with quinapril of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA95184C2 (en) Method for assesment of effectiveness of treatment WITH VERAPAMIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA65054U (en) method for estimation of efficiency of treatment with NADOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
UA78607U (en) method for evaluating the effectiveness of treatment with candesartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of the left ventricular diastolic function by "hypertrophic" type
UA65049U (en) method for estimation of efficiency of treatment with TIMOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
UA78612U (en) method for evaluating the effectiveness of treatment with losartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of left ventricular diastolic function by "hypertrophic" type
UA62007U (en) method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA91262U (en) Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type